October 28, 2009
|
October 22, 2009
By:Marissa Shapiro
Why knowing a drug's risk and preparing for a risk evaluation mitigation strategy early on will considerably benefit a drug's development.
|
October 5, 2009
|
October 1, 2009
By:Juliane Carvalho, Ekopimo Ibia
The region and its regulatory agencies try to keep up with the rapidly growing clinical trials market.
|
October 1, 2009
By:Jill Wechsler
Stiffer enforcement of research standards aims to restore the public's confidence in agency actions.
|
October 1, 2009
By:Peter O'Donnell
The EU struggles to get over its regulatory hurdles in an effort to further R&D success.
|
October 1, 2009
By:Philip Ward
The ICH GCP guideline continues to age and while members of the Institute of Clinical Research voice the need for its revision, industry debates whether changes are necessary.
|
October 1, 2009
By:Marissa Shapiro
Industry news focusing on the people and organizations who work in the clinical trials profession
|
September 24, 2009
|
| 
